Skip to main content
. 2019 Dec 5;14(12):e0226162. doi: 10.1371/journal.pone.0226162

Fig 5. Evaluation of the diagnostic value of DDX24/TCERG1 combined test in the prediction of MS.

Fig 5

Serum response against recombinant TCERG1 and DDX24 in MS (n = 18) and OND (n = 19) patients (cohort 3, Table 1) measured by ELISA (Fig 4). Individual biological replicates are shown. Dotted lines represent the cut-off with the highest Youden’s index calculated for each antigens.